Clinical Trials Browser

OTHER × Glioma × Immunoglobulin G × Clear all

NCT02833701 2023-10-24

Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma

Phase 1 Terminated

Glioblastoma, Glioma

NCT02794883 2022-04-18

Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma

Phase 2 Completed

36 enrolled 13 charts

Glioblastoma, Glioma